Search Results
You are looking at 1 - 2 of 2 items for
- Author: O Vakkuri x
- Refine by access: All content x
Search for other papers by O. Vakkuri in
Google Scholar
PubMed
Search for other papers by H. Rintamäki in
Google Scholar
PubMed
Search for other papers by J. Leppäluoto in
Google Scholar
PubMed
ABSTRACT
The effect of midnight light exposure and pinealectomy on plasma and tissue concentrations of immunoreactive melatonin was studied in the pigeon. Light exposure of 80 min reduced plasma melatonin by 85%. The melatonin concentration fell to 50% of the original value during 12 min. Pinealectomy reduced plasma melatonin so that at midnight about 36 h after the operations the melatonin concentration of pinealectomized pigeons was about 55% of that of sham-operated pigeons. Two weeks after the operations plasma melatonin of pinealectomized pigeons had increased to 64% of that of sham-operated birds. At midday, melatonin levels were unaffected by the operations. The light–dark rhythm of plasma melatonin was also observed in pinealectomized pigeons. In tissue determinations pinealectomy was found to reduce hypothalamic melatonin significantly, suggesting that the pineal is the main source of hypothalamic melatonin. In the Harderian glands a significant increase of melatonin concentrations was observed after pinealectomy. These glands may therefore be the compensatory organs, explaining the presence of circulating melatonin after pinealectomy.
J. Endocr. (1985) 105, 263–268
Search for other papers by O Vakkuri in
Google Scholar
PubMed
Search for other papers by SS Arnason in
Google Scholar
PubMed
Search for other papers by A Pouta in
Google Scholar
PubMed
Search for other papers by O Vuolteenaho in
Google Scholar
PubMed
Search for other papers by J Leppaluoto in
Google Scholar
PubMed
Ouabain was recently isolated from human plasma, bovine hypothalamus and bovine adrenal in attempts to identify endogenous substances inhibiting the cell membrane sodium pump. A number of radioimmunoassays have been developed in order to study the clinical significance of ouabain. The results have been controversial with regard to the presence and chemical nature of plasma ouabain-like immunoreactivity. We have now measured ouabain in healthy and pregnant individuals using solid-phase extraction of plasma samples followed by a new radioimmunoassay with the extraordinary sensitivity of at least 2 fmol/tube (5 pmol/l). Plasma extracts, a previously isolated human plasma ouabain-like compound and bovine hypothalamic inhibitory factor displaced the tracer in parallel and eluted identically with ouabain in high-performance liquid chromatography. Plasma ouabain immunoreactivity was found to be much lower than reported previously: 12.6+/-1.3 pmol/l in healthy men (mean+/-s.e., n=20) and 9.4+/-0.7 pmol/l in women (n=14). In pregnant women (n=28) plasma ouabain concentration was 16.3+/-4.0 pmol/l during the first trimester, 18.8+/-4.3 pmol/l during the second trimester and 24.3+/-4.0 pmol/l during the third trimester (all P<0.01 compared with non-pregnant women). Plasma ouabain 3-5 days after the delivery was 13.6+/-1.1 pmol/l (n=10, P<0.05-0.01 compared with second and third trimesters). The pregnancy-related changes in the plasma concentrations of ouabain resembled those of cortisol. Therefore cortisol was measured from the same plasma samples and a significant positive correlation was found (r=0.512, P=0.006). The similar profiles of plasma ouabain and cortisol during pregnancy and their rapid decreases postpartum are consistent with the adrenal cortical origin of ouabain and also show that the secretions of these hormones are possibly under the control of same factors.